Sedative antidepressants in the treatment of primary insomnia: An evidence-based approach?;Sedierende antidepressiva in der behandlung von patienten mit primärer insomnie: Ein evidenzbasiertes vorgehen?

Psychiatrische Praxis, Supplement

Volumn 34, Issue 1, 2007, Pages

  Lange, Kirsten ^a,b   Geisler, Peter ^a   Klein, Helmfried E ^a   Hajak, Göran ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b UNIVERSITY HOSPITAL REGENSBURG   (Germany)

Author keywords

Antidepressant treatment; Doxepin; Mirtazapine; Primary insomnia; Trazodone; Trimipramine

Indexed keywords

ANTIDEPRESSANT AGENT; DOXEPIN; MIRTAZAPINE; NEFAZODONE; PLACEBO; SEDATIVE AGENT; TRAZODONE; TRIMIPRAMINE;

CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; DRUG EFFICACY; DRUG SAFETY; EVIDENCE BASED MEDICINE; HUMAN; INSOMNIA; MEDICAL LITERATURE; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; UNSPECIFIED SIDE EFFECT;

EID: 33847795334     PISSN: 16118332     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2006-940217     Document Type: Conference Paper

References (23)

1. Hajak G. on behalf of the SINE group. Epidemiology of severe insomnia and its consequences in Germany. Eur Arch Psychiatry Clin Neurosci 2001; 251: 49-56
2. Mellinger GD, Balter MB, Uhlenhuth EH. Insomnia and its treatment. Arch Gen Psychiatry 1985; 42: 225-232
3. Walsh JK, Engelhardt CL. Trends in the pharmacologic treatment of insomnia. J Clin Psychiatry 1992; 53: 10-17
4. Walsh JK, Schweitzer PA. Ten-year trends in the pharmacologic treatment of insomnia. Sleep 1999; 22: 371-375
5. Roehrs T, Roth T. Hypnotic prescription patterns in a large managed-care population. Sleep Medicine 2004; 5: 463-466
6. Walsh JK, Erman M, Erwin CW et al. Subjective hypnotic efficacy of Trazodone and Zolpidem in DSM-III-R primary insomnia. Human Psychopharmacology 1998; 13: 191-198
7. Wallace B, Mendelson MD. A review of the evidence for the efficacy and safety of Trazodone in insomnia. J Clin Psychiatry 2005; 66: 469-476
8. Montgomery I, Oswald K, Adam M et al. Trazodone enhances sleep in subjective qualità but not in objective duration. British Journal of Clinical Pharmacology 1983; 16: 139-144
9. Dolden RN, Dawkins K, Nicholas L. Trazodone and Nefazodone. In: Schatzberg A, Nemeroff CB (eds): The American Psychiatric Publishing Textbook of Psychopharmacology. Washington DC: American Psychiatric Publishing, 2004: 315-325
10. Rausch JL, Pavlinac DM, Newman PE. Complete heart block following a single dose of Trazodone. Am J Psychiatry 1984; 141: 1472-1473
11. Irwin M, Spar JE. Reversible cardiac conduction abnormality associated with Trazodone administration [letter]. Am J Psychiatry 1983; 140: 945-946
12. Levenson JL. Prolonged QT interval after Trazodone overdose [letter]. Am J Psychiatry 1999; 156: 969-970
13. Bucknall C, Brooks D, Curry PV et al. Mianserin and Trazodone for cardiac patients with depression. Eur J Clin Pharmacol 1988; 33: 565-569
14. Carson CC III, Mino RD. Priapism associated with Trazodone therapy. J Urol 1988; 139: 369-437
15. Haria M, Fitton A, McTavish D. Trazodone: A review of its pharmacology, therapeutic use in depression, and therapeutic potential in other disorders. Drugs and Aging 1994; 4: 331-335
16. Neubauer DN. Pharmacologic approaches for the treatment of chronic insomnia. Chronic Insomnia 2003; 5, 3: 16-23
17. Ruigt GS, Kemp B, Groenhout CM et al. Effect of the antidepressant Org 3770 on human sleep. Eur J Clin Pharmacol 1990; 38: 551-554
18. Cluydts RJ, Hajak G, Weerd A De et al. Significant effects on sleep of low dose Mirtazapine in patients with primary insomnia. Sleep. Abstract Supplement 2003; 26: A81-A82
19. Hohagen F, Montero RF, Weiss E et al. Treatment of primary insomnia with Trimipramine: an alternative to benzodiazepine hypnotics? Eur Arch Psychiarty Clin Neurosci 1994; 244: 65-72
20. Riemann D, Voderholzer U, Cohrs S et al. Trimipramine in primary insomnia: Results of a polysomnographic, double-blind, controlled study. Pharmacopsychiatry 2002; 35: 165-174
21. Hajak G, Rodenbeck A, Voderholzer U et al. Doxepin in the treatment of primary insomnia: A placebo-controlled, double-blind, polysomnographic study. J Clin Psychiatry 2001; 62: 453-463
22. Wiegand MH, Galanakis P, Schreiner R. Nefazodone in primary insomnia: an open pilot study. Progress in Neuro-Psychopharmacology & Biological Psychiatry 2004; 28: 1071-1078
23. Wilson S, Argyropoulos S. Antidepressants and sleep. A qualitative review of the literature. Drugs 2005; 65 (7): 927-947